Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices.
Colorectal cancer (CRC) is a feared complication of inflammatory bowel disease (IBD). The cumulative probability of developing this malignancy is significantly higher than in the general population, making IBD the third highest risk condition for CRC. Since CRC is such a concerning complication, it should be no surprise that patients and physicians want to know what the most important risk factors are for its development, as well as potential strategies for reducing these risks. This article reviews the current practice and emerging technologies for detecting and preventing colon cancer in patients with IBD.
Velayos
Fernando
F
University of California, San Francisco, Center for Crohn's and Colitis, 2330 Post Street, Suite 610, San Francisco, CA 94116, USA. fernando.velayos@ucsf.edu
D001706:Biopsy; D003110:Colonic Neoplasms / Q000175:diagnosis* / Q000209:etiology* / Q000473:pathology; D003113:Colonoscopy; D016099:Endoscopy, Gastrointestinal; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D012307:Risk Factors